Methicillin resistance in staphylococci: Molecular and biochemical basis and clinical implications

Clinical Microbiology Reviews

Volumn 10, Issue 4, 1997, Pages 781-791

  Chambers, Henry F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BACTERIAL DNA; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; PENICILLIN BINDING PROTEIN; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; BIOCHEMISTRY; DIFFUSION; DILUTION; GENE LOCUS; MOLECULAR BIOLOGY; MULTIDRUG RESISTANCE; PENICILLIN RESISTANCE; PHENOTYPE; REGULATOR GENE; REVIEW; STAPHYLOCOCCUS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCI; STAPHYLOCOCCUS;

EID: 0030681046     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.10.4.781     Document Type: Review

References (159)

1. Archer, G. L., and D. M. Niemeyer. 1994. Origin and evolution of DNA associated with resistance to methicillin in staphylococci. Trends Microbiol. 2:343-347.
2. Archer, G. L., D. M. Niemeyer, J. A. Thanassi, and M. J. Pucci. 1994. Dissemination among staphylococci of DNA sequences associated with methicillin resistance. Antimicrob. Agents Chemother. 38:447-454.
3. Ardati, K. O., M. C. Thirumoorthi, and A. S. Dajani. 1979. Intravenous trimethoprim-sulfamethoxazole in the treatment of serious infection in children. Pediatr. Pharmacol. Ther. 95:801-806.
4. Barber, M. 1961. Methicillin-resistant staphylococci. J. Clin. Pathol. 14: 385-393.
5. Barg, N., H. Chambers, and D. Kernodle. 1991. Borderline susceptibility to anti-staphylococcal penicillins requires hyperproduction of β-lactamase and an additional factor. Antimicrob. Agents Chemother. 35:1975-1979.
6. Beck, W. D., B. Berger-Bächi, and F. H. Kayser. 1986. Additional DNA in methicillin-resistant Staphylococcus aureus and molecular cloning of mec-specific DNA. J. Bacteriol. 165:373-378.
7. Benner, E. J., and F. H. Kayser. 1968. Growing clinical significance of methicillin-resistant Staphylococcus aureus. Lancet ii:741-744.
8. Berger-Bächi, B. 1983. Insertional inactivation of staphylococcal methicillin resistance by Tn551. J. Bacteriol. 154:479-487.
9. Berger-Bächi, B. 1997. Resist to beta-lactam antibiotics: resistance not mediated by beta-lactamases (methicillin resistance), p. 158-167. In K. B. Crossley and G. L. Archer (ed.), The staphylococci in human disease. Churchill Livingstone, Inc., New York, N.Y.
10. Berger-Bächi, B., L. Barberis-Maino, A. Strässle, and F. H. Kayser. 1989. FemA, a host-mediated factor essential for methicillin resistance in Staphylococcus aureus: molecular cloning and characterization. Mol. Gen. Genet. 219:263-269.
11. Berger-Bächi, B., A. Strässle, and F. H. Kayser. 1986. Characterization of an isogenic set of methicillin-resistant and susceptible mutants of Staphylococcus aureus. Eur. J. Clin. Microbiol. 5:697-701.
12. Boyce, J. M., A. A. Medeiros, E. F. Papa, and C. J. O'Gara. 1990. Introduction of beta-lactamase and methicillin resistance in unusual strains of methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 25: 73-81.
13. Brown, D. F. J., and P. E. Reynolds. 1980. Intrinsic resistance to beta-lactam antibiotics in Staphylococcus aureus. FEBS Lett. 122:275-278.
14. Cantoni, L., A. Wenger, M. Glauser, and J. Bille. 1989. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus in rats. J. Infect. Dis. 159:989-993.
15. Chambers, H. F. Unpublished data.
16. Chambers, H. F. 1987. Coagulase-negative staphylococci resistant to β-lactam antibiotics in vivo produced penicillin-binding protein 2a. Antimicrob. Agents Chemother. 31:919-924.
17. Chambers, H. F. 1993. Detection of methicillin resistant staphylococci. Infect. Dis. Clin. North Am. 7:425-433.
18. Chambers, H. F. 1995. In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for penicillin-binding protein 2a. Antimicrob. Agents Chemother. 39:462-466.
19. Chambers, H. F. 1997. Parenteral antibiotics for treatment of bacteremia and other serious staphylococcal infections, p. 583-601. In K. B. Crossley and G. L. Archer (ed.), The staphylococci in human disease. Churchill Livingstone, Inc., New York, N.Y.
20. Chambers, H. F., G. L. Archer, and M. Matsuhashi. 1989. Low-level methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 33:424-428.
21. Chambers, H. F., and C. J. Hackbarth. 1987. Effect of NaCl and nafcillin on penicillin-binding protein 2a and heterogeneous expression of methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 31: 1982-1988.
22. Chambers, H. F., M. Kartalija, and M. A. Sande. 1995. Ampicillin, sulbactam and rifampin combination therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits. J. Infect. Dis. 171:897-902.
23. Chambers, H. F., and M. Sachdeva. 1990. Binding of beta-lactam antibiotics to penicillin-binding proteins in methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 161:1170-1176.
24. Chambers, H. F., M. J. Sachdeva, and C. J. Hackbarth. 1994. Kinetics of penicillin binding to penicillin binding proteins of Staphylococcus aureus. Biochem. J. 301:139-144.
25. Cohen, S. C., J. Gibson, and H. M. Sweeney. 1972. Phenotypic suppression of methicillin resistance in Staphylococcus aureus by mutant noninducible penicillinase plasmids. J. Bacteriol. 112:682-689.
26. Coles, N. W., and R. Gross. 1967. Liberation of surface-located penicillinase from Staphylococcus aureus. Biochem. J. 102:742-747.
27. Cox, R. A., C. Mallaghan, C. Conquest, and J. King. 1995. Epidemic methicillin-resistant Staphylococcus aureus: controlling the spread outside the hospital. J. Hosp. Infect. 29:107-119.
28. Crossley, K., D. Loesch, B. Landesman, K. Mead, M. Chern, and R. Strate. 1979. An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. I. Clinical studies. J. Infect. Dis. 139:273-279.
29. de Gorgolas, M., P. Aviles, C. Verdejo, and M. L. Guerrero. 1995. Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis. Antimicrob. Agents Chemother. 39:953-957.
30. de Jonge, B. L., Y.-S. Chang, D. Gage, and A. Tomasz. 1992. Peptidoglycan composition in heterogeneous Tn551 mutants of a methicillin-resistant Staphylococcus aureus strain. J. Biol. Chem. 267:11255-11259.
31. de Jonge, B. L., Y.-S. Chang, D. Gage, and A. Tomasz. 1992. Peptidoglycan composition of a highly methicillin-resistant Staphylococcus aureus strain. J. Biol. Chem. 267:11248-11254.
32. de Jonge, B. L., T. Sidow, Y. S. Chang, H. Labischinski, B. Berger-Bächi, D. A. Gage, and A. Tomasz. 1993. Altered muropeptide composition in Staphylococcus aureus strains with an inactivated femA locus. J. Bacteriol. 175:2779-2782.
33. de Lancastre, H., B. L. de Jonge, P. R. Matthews, and A. Tomasz. 1994. Molecular aspects of methicillin resistance in Staphylococcus aureus. J. Antimicrob. Chemother. 33:7-24.
34. de Lancastre, H., and A. Tomasz. 1994. Reassessment of the number of auxiliary genes essential for expression of high-level resistance in Staphylococcus aureus. Antimicrob. Agents. Chemother. 38:2590-2598.
35. Doebbeling, B. N. 1995. The epidemiology of methicillin-resistant Staphylococcus aureus infection and colonization. J. Chemother. 7(Suppl. 3):99-103.
36. Dubin, D. T., P. R. Matthews, S. G. Chikramane, and P. R. Stewart. 1991. Physical mapping of the mec region of an American methicillin-resistant Staphylococcus aureus strain. Aritimicrob. Agents Chemother. 35:1661-1665.
37. Dworkin, R. J., B. L. Lee, M. A. Sande, and H. F. Chambers. 1989. Ciprofloxacin with rifampin: a predominantly oral regimen for right-sided Staphylococcus aureus endocarditis in intravenous drug abusers. Lancet ii:1071-1073.
38. Dyke, K., and P. Gregory. 1997. Resist to beta-lactam antibiotics: resistance mediated by beta-lactamases, p. 139-157. In K. B. Crossley and G. L. Archer (ed.), The staphylococci in human disease. Churchill Livingstone, Inc., New York, N.Y.
39. Entenza, J. M., H. Drugeon, M. P. Glauser, and P. Moreillon. 1995. Treatment of experiment endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 39:1419-1424.
40. Fanti, B., R. Leclercq, Y. Merlé, L. Saint-Julien, C. Veyrat, J. Duval, and C. Carbon. 1995. Critical influence of resistant to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus. Antimicrob. Agents Chemother. 39:400-405.
41. Faville, R. J., Jr., D. E. Zaske, E. L. Kaplan, K. Crossley, L. D. Sabath, and P. G. Quie. 1978. Staphylococcus aureus endocarditis: combined therapy with vancomycin and rifampin. JAMA 240:1963-1965.
42. Ferrero, L., B. Cameron, and J. Crouzet. 1995. Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistance mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 39:1554-1558.
43. 41a. Ford, C. W., J. C. Hamel, D. Stapert, J. K. Moerman, D. K. Hutchison, M. R. Barachyn, and G. E. Zurenko. 1997. Oxazolidinones: new antibacterial agents. Trends Microbiol. 5:196-200.
44. Franciolli, M., J. Bille, M. P. Glauser, and P. Moreillon. 1991. beta-Lactam resistance mechanisms of methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 163:514-523.
45. Georgopapadakou, N. H., B. A. Dix, and Y. R. Mauriz. 1986. Possible physiological functions of penicillin-binding proteins in Staphylococcus aureus. Antimicrob. Agents Chemother. 29:333-336.
46. Georgopapadakou, N. H., and F. Y. Liu. 1980. Binding of beta-lactam antibiotics to penicillin-binding proteins in a Staphylococcus aureus and Streptococcus faecalis: relation to antibacterial activity. Antimicrob. Agents Chemother. 18:834-836.
47. Gerberding, J. L., C. Miick, H. H. Liu, and H. F. Chambers. 1991. Comparison of conventional susceptibility tests with direct detection of penicillin-binding protein 2a in borderline oxacillin-resistant strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 35:2574-2579.
48. Ghuysen, J.-M. 1994. Molecular structures of penicillin-binding proteins and beta-lactamases. Trends Microbiol. 2:372-380.
49. Gillespie, M. T., B. R. Lyon, L. S. Loo, P. R. Matthews, P. R. Stewart, and R. A. Skurray. 1987. Homologous direct repeat sequences associated with mercury, methicillin, tetracycline, and trimethoprim resistance determinants in Staphylococcus aureus. FEMS Microbiol. Lett. 43:165-171.
50. Graninger, W., T. Leitha, S. Breyer, M. Francestoni, K. Lenz, and A. Georgopoulos. 1985. Methicillin-and gentamicin-resistant Staphylococcus aureus: susceptibility to fostomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid, and vancomycin. Drugs Exp. Clin. Res. 11:23-27.
51. Greenburg, R. N., D. J. Kennedy, P. M. Reilly, K. L. Luppen, W. J. Weinandt, M. R. Bollinger, F. Aguirre, F. Kodesch, and A. M. K. Saeed. 1987. Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin. Antimicrob. Agents Chemother. 31:151-155.
52. Guillemin, M. N., H. M. Miles, and M. I. McDonald. 1986. Activity of coumermycin against clinical isolate of staphylococci. Antimicrob. Agents Chemother. 29:608-610.
53. Gustafson, J., A. Strässle, H. Hächler, F. H. Kayser, and B. Berger-Bächi. 1994. The femC locus of Staphylococcus aureus required for methicillin resistance includes the glutamine synthetase operon. J. Bacteriol. 176:1460-1467.
54. Gustafson, J. E., B. Berger-Bächi, A. Strässle, and B. J. Wilkinson. 1992. Autolysis of methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Antimicrob. Agents Chemother. 36:566-572.
55. Gustafson, J. E., and B. J. Wilkinson. 1989. Lower autolytic activity in a homogeneous methicillin-resistant Staphylococcus aureus strain compared to a derived heterogeneous-resistant and susceptible strains. FEMS Microbiol. Lett. 59:107-112.
56. Hackbarth, C. J., and H. F. Chambers. 1993. blaI and blaR1 regulate β-lactamase and PBP 2a production in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 37:1144-1149.
57. Hackbarth, C. J., H. F. Chambers, and M. A. Sande. 1986. Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus. Antimicrob. Agents Chemother. 29:611-613.
58. Hackbarth, C. J., T. Kocagöz, S. Kocagöz, and H. F. Chambers. 1995. Point mutations in Staphylococcus aureus PBP 2 gene affect penicillin-binding kinetics and are associated with resistance. Antimicrob. Agents Chemother. 39:103-106.
59. Hackbarth, C. J., C. Miick, and H. F. Chambers. 1994. Altered production of penicillin-binding protein 2a can affect phenotypic expression of methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 38:2578-2571.
60. Hanaki, H., H. Akagi, Y. Masaru, T. Otani, A. Hyodo, and K. Hiramatsu. 1995. TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 39:1120-1126.
61. Hartman, B. J., and A. Tomasz. 1984. Low-affinity penicillin-binding protein associated with β-lactam resistance in Staphylococcus aureus. J. Bacteriol. 158:513-516.
62. Hartman, B. J., and A. Tomasz. 1986. Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 29:85-92.
63. Hayes, M. V., N. A. C. Curtiss, A. W. Wyke, and J. B. Ward. 1981. Decreased affinity of a penicillin-binding protein for beta-lactam antibiotics in a clinical isolate of Staphylococcus aureus resistant to methicillin. FEMS Microbiol. Lett. 10:119-122.
64. Heldman, A. W., T. V. Hartert, S. C. Ray, E. G. Daoud, T. E. Kowalski, V. J. Pompili, S. D. Sisson, W. C. Tidmore, K. A. vom Eigen, S. N. Goodman, P. S. Lietman, B. G. Petty, and C. Flexner. 1996. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am. J. Med. 101:68-76.
65. Henze, U. U., and B. Berger-Bächi. 1996. Penicillin-binding protein 4 overproduction increases β-lactam resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 40:2121-2125.
66. Henze, U., T. Sidow, J. Wecke, H. Labischinski, and B. Berger-Bächi. 1993. Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus. J. Bacteriol. 175:1612-1620.
67. Hiramatsu, K. 1995. Molecular evolution of MRSA. Microbiol. Immunol. 39:531-543.
68. Hiramatsu, K., K. Asada, E. Suzuki, K. Okonogi, and T. Yokota. 1992. Molecular cloning and nucleotide sequence determination of the regulator region of mecA gene in methicillin-resistant Staphylococcus aureus (MRSA). FEBS Lett. 298:133-136.
69. Hiramatsu, K., H. Kihara, and T. Yokota. 1992. Analysis of borderline-resistant strains of methicillin-resistant Staphylococcus aureus. Microbiol. Immunol. 36:445-453.
70. Hiramatsu, K., and N. Konodo. 1995. Cloning of a novel genetic element conferring high methicillin resistance to Staphylococcus aureus, abstr. C116. In Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
71. Hiramatsu, K., N. Konodo, and T. Ito. 1996. Genetic basis for molecular epidemiology of MRSA. J. Infect. Chemother. 2:117-129.
72. Hiramatsu, K., E. Suzuki, H. Takayama, Y. Katayama, and T. Yokota. 1990. Role of penicillinase plasmids in stability of the mecA gene in methicillin-resistant Staphulococcus aureus. Antimicrob. Agents Chemother. 34:600-604.
73. Hirano, L., and A. S. Bayer. 1991. β-Lactam-β-lactamase-inhibitor combinations are active in experimental endocarditis caused by β-lactamase-producing oxacillin-resistant staphylococci. Antimicrob. Agents Chemother. 35:685-690.
74. Hürlimann-Dalel, R. L., C. Ryffel, F. H. Kayser, and B. Berger-Bächi. 1992. Survey of the methicillin resistance-associated genes mecA, mecR1-mecI, and femA-femB in clinical isolates of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 36:2617-2621.
75. Jevons, M. P. 1961. Letter. Br. Med. J. 1:124-125.
76. Jones, R. N., M. S. Barret, and M. E. Erwin. 1997. In vitro activity and spectrum of LY333328, a novel glycopeptide derivative. Antimicrob. Agents Chemother. 41:488-493.
77. Kaatz, G. W., S. M. Seo, S. L. Barriere, L. M. Albrecht, and M. J. Rybak. 1989. Ciprofloxacin and rifampin, alone and in combination for therapy of experimental Staphylococcus aureus endocarditis. Antimicrob. Agents Chemother. 33:1184-1187.
78. Kaatz, G. W., S. M. Seo, N. J. Dorman, and S. A. Lerner. 1990. Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis. J. Infect. Dis. 162:103-108.
79. Kang, S. L., M. J. Rybak, B. J. McGrath, G. W. Kaatz, and S. M. Seo. 1994. Pharmacokinetics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model. Antimicrob. Agents Chemother. 38:2702-2709.
80. Kernodle, D. S., C. S. Stratton, L. W. McMurray, J. R. Chipley, and P. A. McGraw. 1989. Differentiation of beta-lactamase variants in Staphylococcus aureus by substrate hydrolysis profiles. J. Infect. Dis. 159:103-108.
81. Kim, T. K., and J. R. Chipley. 1974. Effect of salts on penicillinase release by Staphylococcus aureus. Microbios 10A:55-63.
82. Klimek, J. J., F. J. Marsik, R. C. Bartlett, B. Weir, P. Shea, and R. Quintilliani. 1976. Clinical, epidemiologic and bacteriologic observations of an outbreak of methicillin-resistant Staphylococcus aureus at a large community hospital. Am. J. Med. 61:340-345.
83. Knapp, C. C., M. D. Ludwig, and J. A. Washington. 1994. Evaluation of BBL Crystal MRSA ID system. J. Clin. Microbiol. 32:2588-2589.
84. Knapp, C. C., M. D. Ludwig, J. A. Washington, and H. F. Chambers. 1996. Evaluation of the Vitek GPS-SA card for testing of borderline susceptible staphylococci that lack mec against oxacillin. J. Clin. Microbiol. 34:1603-1605.
85. Kreiswirth, B., J. Kornblum, R. D. Arbeit, W. Eisner, J. N. Maslow, A. McGeer, D. E. Low, and R. P. Novick. 1993. Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science 259:227-230.
86. Kuhl, S. A., P. A. Pattee, and J. N. Baldwin. 1978. Chromosomal map location of the methicillin resistance determinant in Staphylococcus aureus. J. Bacteriol. 135:460-465.
87. Kuwahara-Arai, K. Kondo, S. Hori, E. Tateda-Suzuki, and K. Hiramatsu. 1996. Suppression of methicillin resistance in a mecA-containing premethicillin-resistant Staphylococcus aureus is caused by the mecl-mediated repression of PBP2′ production. Antimicrob. Agents Chemother. 40:2680-2685.
88. Levine, D. P., R. D. Cushing, J. Jui, and W. J. Brown. 1982. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Ann. Intern. Med. 97:330-338.
89. Levine, D. P., B. S. Fromm, and B. R. Reddy. 1991. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann. Intern. Med. 115:674-680.
90. Levitz, R. E., and R. Quintilliani. 1984. Trimethoprim-sulfamethoxazole for bacterial meningitis. Ann. Intern. Med. 100:881-890.
91. Maidhof, H., B. Reinike, P. Blümel, B. Berger-Bächi, and H. Labischinski. 1991. femA, which encodes a factor essential for expression of methicillin resistance, affects glycine content of peptidoglycan in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. J. Bacteriol. 173: 3507-3513.
92. Maki, H., T. Yamaguchi, and K. Murakami. 1994. Cloning and characterization of a gene affecting the methicillin resistance level and the autolysis rate in Staphylococcus aureus. J. Bacteriol. 176:4993-5000.
93. Markowitz, N., E. L. Quinn, and L. D. Saravolatz. 1992. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann. Intern. Med. 117:390-398.
94. Massanari, R. M., and S. T. Denta. 1978. The efficacy of rifampin as adjunctive therapy in selected cases of staphylococcal endocarditis. Chest 73:371-375.
95. Massida, O., M. P. Montanari, M. Mingoia, and P. E. Valrado. 1994. Cloning and expression of the penicillinase from a borderline methicillin-resistant Staphylococcus aureus strain in Escherichia coli. FEMS Microbiol. Lett. 119:263-270.
96. Massida, O., M. P. Montanari, and P. E. Valrado. 1992. Evidence for a methicillin-hydrolyzing beta-lactamase in Staphylococcus aureus strains with borderline susceptibility to this drug. FEMS Microbiol. Lett. 92:223-227.
97. Matsuhashi, M., M. D. Song, F. Ishimo, M. Wachi, M. Doi, M. Inoue, K. Ubukata, N. Yamashita, and M. Konno. 1986. Molecular cloning of the gene of a penicillin-binding protein supposed to cause high resistance to β-lactam antibiotics in Staphylococcus aureus. J. Bacteriol. 167:975-980.
98. Matthews, P. R., K. C. Reed, and P. R. Stewart. 1987. The cloning of chromosomal DNA associated with methicillin and other resistances in Staphylococcus aureus. J. Gen. Microbiol. 133:1919-1929.
99. Matthews, P. R., and P. R. Stewart. 1984. Resistance heterogeneity in methicillin-resistant Staphylococcus aureus. FEMS Microbiol. Lett. 22:161-166.
100. Matthews, P. R., and P. R. Stewart. 1988. Amplification of a section of chromosomal DNA in methicillin-resistant Staphylococcus aureus following growth in high concentrations of methicillin. J. Gen. Microbiol. 134:1455-1464.
101. McDonald, C. L., W. E. Maher, and R. J. Fass. 1995. Revised interpretation of oxacillin MICs for Staphylococcus epidermidis based on mecA detection. Antimicrob. Agents Chemother. 39:982-984.
102. McDougal, L. K., and C. Thornsberry. 1986. The role of β-lactamase in staphylococcal resistance to penicillinase-resistant penicillin and cephaloβ sporin. J. Clin. Microbiol. 23:832-839.
103. McMurray, L. W., D. S. Kernodle, and N. L. Barg. 1990. Characterization of a widespread strain of methicillin-susceptible Staphylococcus aureus associated with nosocomial infections. J. Infect. Dis. 162:759-762.
104. Miller, M. H., M. A. Wexler, and N. H. Steigbigel. 1978. Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants. Antimicrob. Agents Chemother. 14:336-343.
105. Moreno, F., C. Criso, J. H. Jorgensen, and J. E. Patterson. 1995. Methicillin-resistant Staphylococcus aureus as a community organism. Clin. Infect. Dis. 21:1308-1312.
106. Morton, T. M., J. L. Johnston, J. Patterson, and G. L. Archer. 1995. Characterization of a conjugative staphylococcal mupirocin resistance plasmid. Antimicrob. Agents Chemother. 39:1272-1280.
107. Mulligan, M. E., P. J. Ruane, L. Johnston, P. Wong, J. P. Wheelock, K. MacDonald, J. F. Reinhardt, C. C. Johnson, B. Statner, I. Blomquist, J. McCarthy, W. O'Brien, S. Gardner, L. Hammer, and D. M. Citron. 1987. Ciprofloxacin for eradication of methicillin-resistant Staphylococcus aureus colonization. Am. J. Med. 82(Suppl. 2):215-219.
108. Murakami, K., and A. Tomasz. 1989. Involvement of multiple genetic determinants in high-level methicillin resistance in Staphylococcus aureus. J. Bacteriol. 171:874-879.
109. National Committee for Clinical Laboratory Standards. 1993. Dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 2nd ed. NCCLS document M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
110. Neu, H. C. 1988. Bacterial resistance to fluoroquinolones. Rev. Infect. Dis. 10(Suppl. 1):S57-S63.
111. Ng, E. Y., M. Trucksis, and D. C. Hooper. 1996. Quinolone resistance mutations in topoisomerase IV: relationship to flqA locus and genetic evidence that topoisomerase IV is the primary target of fluoroquinolones in Staphylococcus aureus. Antimicrob. Agents Chemother. 40:1881-1888.
112. Nicolau, D. P., C. D. Freeman, C. H. Nightingale, C. J. Coe, and R. Quintiliani. 1994. Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 38:1515-1518.
113. Niemeyer, D. M., M. J. Pucci, S. A. Thanassi, V. K. Sharma, and G. L. Archer. 1996. Role of mecA transcriptional regulation in the phenotypic expression of methicillin resistance in Staphylococcus aureus. J. Bacteriol. 178:5464-5471.
114. Noble, W. C., Z. Virani, and R. G. Cree. 1992. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 72:196-198.
115. Novak, S. M., J. Hindler, and D. A. Bruckner. 1993. Reliability of two novel methods, Almar and E test, for detection of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 31:3056-3057.
116. Ornelas-Soares, A., H. de Lancastre, B. L. de Jonge, and A. Tomasz. 1994. Reduced methicillin resistance in a new Staphylococcus aureus transposon mutant that incorporates muramyl dipeptides into the cell wall peptidoglycan. J. Biol. Chem. 269:27246-27250.
117. Píriz-Durán, S., F. H. Kayser, and B. Berger-Bächi. 1996. Impact of sar and agr on methicillin resistance in Staphylococcus aureus. FEMS Microbiol. Lett. 141:255-260.
118. Qoronfleh, M. W., and B. J. Wilkinson. 1986. Effects of growth of methicillin-resistant and -susceptible Staphylococcus aureus in the presence of β-lactams on peptidoglycan structure and susceptibility to lytic enzymes. Antimicrob. Agents Chemother. 29:250-257.
119. Reynolds, P. E. 1988. The essential nature of staphylococcal penicillin-binding proteins, p. 343-351. In P. Actor, L. Daneo-Moore, M. L. Higgins, M. R. Salton, and G. D. Shockman (ed.), Antibiotic inhibition of bacterial cell surface assembly and function. American Society for Microbiology, Washington, D.C.
120. Reynolds, P. E., and C. Fuller. 1986. Methicillin-resistant strains of Staphylococcus aureus: presence of identical additional penicillin-binding protein in all strains examined. FEMS Microbiol. Lett. 33:251-254.
121. Rolinson, G. N. 1961. Letter. Br. Med. J. 1:125-126.
122. Ryffel, C., F. H. Kayser, and B. Berger-Bächi. 1992. Correlation between regulation of mecA transcription and expression of methicillin resistance in staphylococci. Antimicrob. Agents Chemother. 36:25-31.
123. Ryffel, C., A. Strässle, F. H. Kayser, and B. Berger-Bächi. 1994. Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 38:724-728.
124. Sabath, L. D., and S. J. Wallace. 1974. Factors influencing methicillin resistance in staphylococci. Ann. N. Y. Acad. Sci. 236:258-266.
125. Sanders, C. C., W. E. Sanders, Jr., and K. S. Thomson. 1995. Fluoroquinolone resistance in staphylococci: new challenges. Eur. J. Clin. Microbiol. Infect. Dis. 14(Suppl. 1):S6-S11.
126. Saravolatz, L. D., D. J. Pohold, and L. M. Arking. 1982. Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks. Ann. Intern. Med. 97:325-329.
127. Schaefler, S. 1989. Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones. J. Clin. Microbiol. 27:335-336.
128. Schwalbe, R. S., J. T. Stapleton, and P. H. Gilligan. 1987. Emergence of vancomycin resistance in coagulase-negative staphylococci. N. Engl. J. Med. 316:927-931.
129. Seligman, S. J. 1966. Penicillinase-negative variants of methicillin-resistant Staphylococcus aureus. Nature (London) 209:994-996.
130. Skinner, S., B. Inglis, P. R. Matthews, and P. R. Stewart. 1988. Mercury and tetracycline resistance genes and flanking repeats associated with methicillin resistance on the chromosome of Staphylococcus aureus. Mol. Microbiol. 2:289-297.
131. Song, M. D., M. Wachi, M. Doi, F. Ishino, and M. Matsuhashi. 1987. Evolution of an inducible penicillin-target protein in methicillin-resistant Staphylococcus aureus by gene fusion. FEBS Lett. 221:167-171.
132. Stewart, G. T., and R. J. Holt. 1963. Evolution of natural resistance to the newer penicillin. Br. Med. J. 1:308-311.
133. Stewart, P. R., D. T. Dubin, S. G. Chikramane, B. Inglis, P. R. Matthews, and S. M. Poston. 1994. IS257 and small plasmid insertions in the mec region of the chromosome of Staphylococcus aureus. Plasmid 31:12-20.
134. Strandén, A. M., K. Ehlert, H. Labischinski, and B. Berger-Bächi. 1997. Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus. J. Bacteriol. 179:9-16.
135. Sumita, Y., H. Nouda, K. Kanazawa, and M. Fukasawa. 1995. Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 39:910-916.
136. Suzuki, E., K. Hiramatsu, and T. Yokota. 1992. Survey of methicillin-resistant clinical strains of coagulase-negative staphylococci for mecA gene distribution. Antimicrob. Agents Chemother. 36:429-434.
137. Suzuki, E., K. Kuwahara-Arai, J. F. Richardson, and K. Hiramatsu. 1993. Distribution of mec regulator genes in methicillin-resistant clinical strains. Antimicrob. Agents Chemother. 37:1219-1226.
138. Tesch, W., C. Ryffel, A. Strässle, F. H. Kayser, and B. Berger-Bächi. 1990. Evidence of a novel staphylococcal mec-encoded element (mecR) controlling expression of penicillin-binding protein 2′. Antimicrob. Agents Chemother. 34:1703-1706.
139. Thauvin-Eliopoulos, C., L. B. Rice, G. M. Eliopoulos, and R. C. Moellering, Jr. 1990. Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by a β-lactamase-hyperproducing Staphylococcus aureus. Antimicrob. Agents Chemother. 34:728-732.
140. Thornsberry, C., and L. K. McDougal. 1983. Successful use of broth microdilution insusceptibility tests for methicillin-resistant (heteroresistant) staphylococci. J. Clin. Microbiol. 18:1084-1091.
141. Tokue, Y., S. Shoji, K. Satoh, A. Watanabe, and M. Motomiya. 1992. Comparison of a polymerase chain reaction assay and a conventional microbiologic method for detection of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 36:6-9.
142. Tomasz, A., H. B. Drugeon, H. M. de Lencastre, D. Jabes, L. McDougal, and J. Bille. 1989. New mechanism for methicillin resistance in Staphylococcus aureus: clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity. Antimicrob. Agents Chemother. 33:1899-1874.
143. Trees, D. L., and J. J. Iandolo. 1988. Identification of a Staphylococcus aureus transposon (Tn429/) that carries the methicillin resistance gene(s). J. Bacteriol. 170:149-154.
144. Ubukata, K., R. Nonoguchi, M. Matsuhashi, and M. Konno. 1989. Expression and inducibility in Staphylococcus aureus of the mecA gene, which encodes a methicillin-resistant S. aureus-specific penicillin-binding protein. J. Bacteriol. 171:2882-2885.
145. Ubukata, K., R. Nonoguchi, M. D. Song, M. Matsuhashi, and M. Konno. 1990 Homology of mecA gene in methicillin-resistant Staphylococcus haemolyticus and Staphylococcus simulans to that of Staphylococcus aureus. Antimicrob. Agents Chemother. 34:170-172.
146. Unal, S., K. Werner, P. DeGirolami, F. Barsanti, and G. Eliopoulos. 1994. Comparison of tests for detection of methicillin-resistant Staphylococcus aureus in a clinical microbiology laboratory. Antimicrob. Agents Chemother. 38:345-347.
147. Utsui, Y., and T. Yokota. 1985. Role of an altered penicillin-binding protein in methicillin-and cephem-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 28:397-103.
148. Van Der Auwera, R., and F. Meunier-Carpenter. 1983. Clinical study of combination therapy with oxacillin and rifampin for staphylococcal infection. Rev. Infect. Dis. 5(Suppl. 3):S515-S522.
149. Walsh, C. T. 1993. Vancomycin resistance: decoding the molecular logic. Science 261:308-309.
150. Walsh, T. J., F. Auger, B. A. Tatem, S. L. Hansen, and H. C. Standiford. 1986. Novobiocin and rifampicin in combination against methicillin-resistant Staphylococcus aureus: an in-vitro comparison with vancomycin and rifampicin. J. Antimicrob. Chemother. 17:75-82.
151. Watanakunakorn, C., and J. C. Tisone. 1982. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains. Antimicrob. Agents Chemother. 22:903-905.
152. Waxman, D. J., and J. L. Strominger. 1983. Penicillin-binding proteins and the mechanism of action of beta-lactam antibiotics. Annu. Rev. Biochem. 52:825-869.
153. Whitener, C., G. M. Caputo, M. R. Weirekamp, A. W. Karchmer. 1993. Endocarditis due to coagulase-negative staphylococci: microbiologic, epidemiologic, and clinical considerations. Infect. Dis. Clin. North Am. 7:81-96.
154. Woods, G. L., G. S. Hall, I. Rutherford, K. J. Pratt, and C. C. Knapp. 1986. Detection of methicillin-resistant Staphylococcus epidermidis. J. Clin. Microbiol. 24:349-352.
155. Wu, C. Y., J. Hoskins, L. C. Blaszczak, D. A. Preston, and P. L. Skatrud. 1992. Construction of a water-soluble form of penicillin-binding protein 2a from a methicillin-resistant Staphylococcus aureus isolate. Antimicrob. Agents Chemother. 36:533-539.
156. Wu, C. Y., W. E. Alborn, Jr., J. E. Flokowitsch, J. Hoskins, S. Unal, L. C. Blaszczak, D. A. Preston, and P. L. Skatrud. 1994. Site-directed mutagenesis of the mecA gene from a methicillin-resistant strain of Staphylococcus aureus. J. Bacteriol. 176:443-449.
157. Wu, S., C. Piscitelli, H. deLencastre, and A. Tomasz. 1996. Tracking the evolutionary origin of the methicillin resistance gene: cloning and sequencing of a homologue of mecA from a methicillin susceptible strain of Staphylococcus sciuri. Microb. Drug Resistance 2:435-441.
158. York, M. K., L. Gibbs, F. Chehab, and G. F. Brooks. 1996. Comparison of PCR detection of mecA with standard susceptibility testing methods to determine methicillin resistance in coagulase-negative staphylococci. J. Clin. Microbiol. 34:249-253.
159. Yuk, J. H., M. C. Dignani, R. L. Harris, M. W. Bradshaw, and T. W. Williams. 1991. Minocycline as an alternative antistaphylococcal agent. Rev. Infect. Dis. 13:1023-1024.